| 注册
首页|期刊导航|河北医学|血清肿瘤标记物对非小细胞肺癌的诊断价值

血清肿瘤标记物对非小细胞肺癌的诊断价值

刘广军 谢宗涛

河北医学2012,Vol.18Issue(3):297-300,4.
河北医学2012,Vol.18Issue(3):297-300,4.DOI:10.3969/j.issn.1006-6233.2012.03.005

血清肿瘤标记物对非小细胞肺癌的诊断价值

Diagnostic Value of Single and Combined Determination of Serum TPS Cyfra21-1 and Ferritin in patients with NSCLC

刘广军 1谢宗涛1

作者信息

  • 1. 苏州大学附属第四医院,江苏,无锡,214062
  • 折叠

摘要

Abstract

Objective: To investigate the diagnostic value of single and combined determination of serum tissue polypeptide specific antigen( TPS ), cytokeratin 19 fragment(Cyfra21-1 ) and ferritin in patients with non-small cell lung cancer( NSCLC ). Method: The levels of serum TPS were detected in 108 patients with NSCLC and 86 cases of healthy adults by enzyme-linked immunosorbent assay( ELASA ),and the levels of Cyfra21-1 and ferritin were detected by electrochemiluminescence. Result: The serum levels and positive rates of the three tumor markers in lung cancer group were significantly higher than those in healthy adults( P <0. 01 ). TPS showed higher sensitivity than the other two tumor markers in the diagnosis of pulmonary ade-nocarcinoma( P<0. 05 );The serum levels and positive rates of Cyfra21-1 in squamous carcinoma group were significantly higher than those in adenocarcinoma group( P<0. 01 ). TPS showed the highest sensitivity and Cyfra21-1 showed the highest sensitivity in single tumor marker detection; Their combined detection could reduce the specificity to a certain extent,but could significantly improve the sensitivity and the accuracy( P< 0. 01 ). Conclusion: The single and combined detection TPS,cyfra21-l and ferritin has high clinical value in the diagnosis of NSCLC and the differentiation of pathology types.

关键词

非小细胞肺癌/肿瘤标记物/组织多肽特异性抗原/细胞角蛋白19片段

Key words

Non-small cell lung cancer/ Tumor marker/ Tissue polypeptide specific antigen/ Cytokeratin 19 fragment

引用本文复制引用

刘广军,谢宗涛..血清肿瘤标记物对非小细胞肺癌的诊断价值[J].河北医学,2012,18(3):297-300,4.

河北医学

OACSTPCD

1006-6233

访问量0
|
下载量0
段落导航相关论文